pentobarbital will lower the extent or impact of buprenorphine, prolonged-performing injection by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. People who transfer to buprenorphine extensive-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers should be monitored to be certa